Q32 Bio Inc.

NASDAQ: QTTB · Real-Time Price · USD
1.98
0.10 (5.32%)
At close: Aug 15, 2025, 3:59 PM
1.99
0.41%
After-hours: Aug 15, 2025, 07:01 PM EDT

Q32 Bio Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
54.83M 65.48M 77.97M 89.08M 97.66M 115.51M 39.27M 36.26M 76.8M 39.45M 33.99M 43.16M 176.19M 248.13M 108.38M 95.83M 116.31M 104.42M
Short-Term Investments
n/a n/a n/a n/a 9.99M 19.8M 43.39M 74.19M 50.27M 110.57M 141.04M 157.91M 49.34M 8M 47.49M 91.72M 96.98M 84.23M
Long-Term Investments
647K 2.53M 2.6M 2.6M 3.92M 4.72M n/a 13.96M 17.32M 23.04M 25.81M 27.13M 29.3M 30.91M 1.95M 1.27M 1.27M 1.27M
Other Long-Term Assets
570K 1.09M 763K 687K 1.1M 1.75M n/a -7.63M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Receivables
n/a 555K 555K 563K 563K 563K n/a 680K n/a n/a 1.06M n/a n/a n/a n/a 100K 200K 300K
Inventory
n/a n/a n/a n/a n/a 2.1M n/a 2.06M n/a n/a -1.06M n/a n/a n/a n/a n/a n/a n/a
Other Current Assets
77K 93K 396K 229K 51K 67K 1.26M 101K 4.26M 3.56M 146K 12.13M 12.92M 6.32M 36.04M 4.17M 4.44M 2.7M
Total Current Assets
58.32M 68.63M 81.88M 93.9M 111.62M 138.04M 83.91M 39.1M 131.34M 153.58M 181.01M 213.2M 238.44M 262.45M 191.91M 191.82M 217.94M 191.65M
Property-Plant & Equipment
6.58M 6.82M 7.09M 7.36M 7.57M 7.82M 650K 8.34M 20.68M 21.26M 21.64M 22.32M 16.87M 17.59M 17.86M 37.73M 39.71M 41.77M
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
7.79M 10.44M 10.46M 10.64M 12.59M 14.29M 222.21M 14.67M 38M 44.3M 47.45M 49.45M 46.17M 48.51M 19.81M 39M 40.98M 43.05M
Total Assets
66.12M 79.07M 92.33M 104.54M 124.21M 152.33M 306.12M 53.77M 169.34M 197.88M 228.47M 262.65M 284.61M 310.96M 211.72M 230.82M 258.92M 234.7M
Account Payables
910K 2.71M 2.99M 1.26M 2.48M 4.96M 3.23M 1.83M 3.39M 3.63M 1.44M 4.83M 3.76M 9.88M 2.37M 3.52M 5.7M 4.88M
Deferred Revenue
n/a n/a n/a n/a n/a 18.27M n/a 24.8M n/a 354K 1.16M 1.96M 2.76M 3.21M 3.21M 3.21M 4.01M 5.18M
Short-Term Debt
6.88M 4.66M 3.1M 1.53M n/a 3.09M 1.32M 37.81M 1.7M 1.63M 32.4M 1.49M 410K 435K 246K 1.96M 2.14M 2.32M
Other Current Liabilities
2.26M 3.61M 5.68M 6.15M 9.28M 18.94M 7.02M 2.17M 17.84M 12.89M 2.79M 16.97M 13.8M 7.27M 11.41M 10.02M 7.69M 2.1M
Total Current Liabilities
11.53M 14.58M 16.46M 14.38M 17.19M 32.95M 11.57M 71.84M 22.94M 18.51M 22.58M 25.25M 20.73M 20.8M 17.23M 18.7M 19.53M 17.81M
Long-Term Debt
6.52M 8.04M 9.56M 11.07M 12.55M 9.4M n/a 5.01M n/a n/a 5.07M n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
55M 55M 55M 55M 55M 55.11M n/a 111.44M n/a n/a 4.74M n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Liabilities
66.82M 68.51M 70.19M 71.86M 73.5M 70.61M 221.56M 138.38M 27.02M 27.48M 27.92M 28.34M 23.59M 23.9M 24.84M 13.54M 14.81M 16.06M
Total Liabilities
78.35M 83.08M 86.66M 86.25M 90.7M 103.56M 233.13M 210.22M 49.96M 45.98M 50.49M 53.59M 44.32M 44.7M 42.07M 32.24M 34.34M 33.87M
Total Debt
18.7M 18.8M 18.9M 19.42M 19.85M 20.15M 1.32M 49.73M 28.72M 29.1M 29.48M 29.83M 24M 23.98M 23.93M 13.54M 14.19M 2.32M
Common Stock
2K 2K 2K 2K 2K 2K 6K 1K 6K 6K 6K 6K 6K 6K 6K 6K 6K 5K
Retained Earnings
-255.33M -245.84M -234.81M -220.63M -203.03M -186.05M -542.1M -160.01M -493.02M -457.98M -429.14M -394.84M -361.12M -332.03M -424.13M -390.55M -359.94M -329.44M
Comprehensive Income
n/a n/a n/a -1K -1K -5K -5K -36K -88K -182K -404K -457K -41K n/a -7K -5K 2K -23K
Shareholders Equity
-12.23M -4.01M 5.67M 18.3M 33.51M 48.77M 72.99M -156.45M 119.38M 151.9M 177.98M 209.06M 240.29M 266.25M 169.65M 198.57M 224.58M 200.83M
Total Investments
647K 2.53M 2.6M 2.6M 13.91M 24.53M 43.39M 88.14M 67.59M 133.61M 166.85M 185.04M 78.63M 38.91M 49.44M 93M 98.25M 85.51M